|
Mr. Martin has been a driver in building shareholder value during the last ten years in three companies. Mr. Martin was appointed the Company’s Chief Executive Officer in February 2007 and has served on the Board since August 15, 2006. Previously, Mr. Martin was Chief Operating Officer for FoxHollow Technologies, (IPO 2004) and directed its commercial plan. Prior to FoxHollow, Mr. Martin was VP of Global Sales for Rita Medical Systems, (IPO 2000). Previous to Rita Medical, Mr. Martin was Director of U.S. Sales for CardioThoracic Systems, (IPO 1996). Mr. Martin has also held sales and sales management positions for Procter & Gamble, Boston Scientific and Guidant Corporation. Mr. Martin currently serves on two boards. | 